These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 31315446)

  • 41. Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes.
    Diabetes Research in Children Network (DirecNet) Study Group
    Pediatr Diabetes; 2006 Feb; 7(1):32-8. PubMed ID: 16489972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continuous glucose monitoring and intensive treatment of type 1 diabetes.
    ; Tamborlane WV; Beck RW; Bode BW; Buckingham B; Chase HP; Clemons R; Fiallo-Scharer R; Fox LA; Gilliam LK; Hirsch IB; Huang ES; Kollman C; Kowalski AJ; Laffel L; Lawrence JM; Lee J; Mauras N; O'Grady M; Ruedy KJ; Tansey M; Tsalikian E; Weinzimer S; Wilson DM; Wolpert H; Wysocki T; Xing D
    N Engl J Med; 2008 Oct; 359(14):1464-76. PubMed ID: 18779236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Moreno-Fernandez J; Pazos-Couselo M; González-Rodriguez M; Rozas P; Delgado M; Aguirre M; Garcia-Lopez JM
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):556-563. PubMed ID: 29907546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial.
    Dicembrini I; Pala L; Caliri M; Minardi S; Cosentino C; Monami M; Mannucci E
    Diabetes Obes Metab; 2020 Aug; 22(8):1286-1291. PubMed ID: 32166907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
    Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
    Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers.
    Commissariat PV; Boyle CT; Miller KM; Mantravadi MG; DeSalvo DJ; Tamborlane WV; Van Name MA; Anderson BJ; DiMeglio LA; Laffel LM
    Diabetes Technol Ther; 2017 Jun; 19(6):363-369. PubMed ID: 28581817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).
    Ólafsdóttir AF; Polonsky W; Bolinder J; Hirsch IB; Dahlqvist S; Wedel H; Nyström T; Wijkman M; Schwarcz E; Hellman J; Heise T; Lind M
    Diabetes Technol Ther; 2018 Apr; 20(4):274-284. PubMed ID: 29608107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.
    Rodbard D; Jovanovic L; Garg SK
    Diabetes Technol Ther; 2009 Dec; 11(12):757-65. PubMed ID: 20001676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuous glucose monitoring systems in well-controlled children with type 1 diabetes mellitus.
    M Kowalczyk E; Adamczyk M; Pietrzyk J; Jastrzębska B; Szypowska A
    Pediatr Endocrinol Diabetes Metab; 2021; 27(3):151-158. PubMed ID: 34596369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.
    McAuley SA; de Bock MI; Sundararajan V; Lee MH; Paldus B; Ambler GR; Bach LA; Burt MG; Cameron FJ; Clarke PM; Cohen ND; Colman PG; Davis EA; Fairchild JM; Hendrieckx C; Holmes-Walker DJ; Horsburgh JC; Jenkins AJ; Kaye J; Keech AC; King BR; Kumareswaran K; MacIsaac RJ; McCallum RW; Nicholas JA; Sims C; Speight J; Stranks SN; Trawley S; Ward GM; Vogrin S; Jones TW; O'Neal DN
    BMJ Open; 2018 Jun; 8(6):e020274. PubMed ID: 29886443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods.
    JDRF CGM Study Group
    Diabetes Technol Ther; 2008 Aug; 10(4):310-21. PubMed ID: 18828243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experience with the Enlite sensor in a multicenter pediatric study.
    Evans K; Richardson C; Landry A; Muileboom J; Cormack L; Lawson ML;
    Diabetes Educ; 2015 Feb; 41(1):31-7. PubMed ID: 25512220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring.
    Telo GH; Volkening LK; Butler DA; Laffel LM
    Diabetes Technol Ther; 2015 Jun; 17(6):373-8. PubMed ID: 25749206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
    Heptulla RA; Allen HF; Gross TM; Reiter EO
    Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parental expectations before and after 12-month experience with video consultations combined with regular outpatient care for children with type 1 diabetes: a qualitative study.
    von Sengbusch S; Doerdelmann J; Lemke S; Lange K; Hiort O; Katalinic A; Frielitz FS
    Diabet Med; 2021 Jun; 38(6):e14410. PubMed ID: 32969088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial.
    Moreno-Fernandez J; Gómez FJ; Gálvez Moreno MÁ; Castaño JP
    J Diabetes Res; 2016; 2016():4171789. PubMed ID: 28004007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.